Furthermore, other studies have shown that the expression levels of TOP2A/Bare significantly higher in human GBM and that TOP2B transcription is corrected in PDGF (+) PTEN (−/−) or PDGF (+) PTEN (−/−) P53 (−/−) models by susceptibility to cancer drugs [20]. This evidence concerns the gene TOP2A and cancer.